Morrison DJ, Mackay WG, Edwards CA, Preston T, Dodson B, Weaver LT
Notably, European psychiatric societies, such as NICE and BAP, provide more comprehensive recommendations for baseline and ongoing monitoring of cardiometabolic risk such as blood pressure, weight, glycemic control, lipid profiles, and ECG, than their American counterparts (69)
The standard approach involves: Starting at 2.5 mg weekly for at least four weeks Increasing by 2.5 mg increments at four-week intervals Delaying dose escalation if gastrointestinal symptoms are problematic Recognizing that slower titration, while extending the time to reach therapeutic doses, may improve long-term adherence Injection Technique Optimization can reduce local reactions: Rotating injection sites (abdomen, thigh, upper arm) Allowing the medication to reach room temperature before injection Using proper technique to minimize tissue trauma Hypoglycemia Prevention requires careful attention when tirzepatide is combined with other glucose-lowering medications
Stick to compounds with established human safety data and verifiable sourcing
Mid-luteal progesterone testing through your doctor is the gold standard